Topics:

Rheumatic Diseases

Five Reasons Your Patients Should Join Arthritis Power

A new symptom-tracking app isn't merely about helping your patients. It's about helping them help everyone with their condition by sharing their experience in a systematic way. Founder Jeffrey Curtis MD describes the new registry and its goals.

Rheumatic Diseases

rheumatoid arthritis

One very targeted clue to treatment failure: An observational study from Israel identifies Sephardic Jews as more likely than Ashkenazim to form antibodies against the biologic drug infliximab.

rheumatoid arthritis

Slides present key points from a Twitter-based journal club, pondering a randomized study of tapering TNF inhibitors in rheumatoid arthritis. Many questions about the study design. More ask about practices already in use (addressed in Part 2).

gout

Expert rheumatologists examine patterns of treatment failure in gout, in light of six recent guidelines on the condition. This brief slide show based on their review summarizes basics about the guidelines and the clues to optimal treatment, linking to the review itself.

A new app-based registry focusing on rheumatoid and psoriatic arthritis and ankylosing spondylitis aims to use patient-generated data to resolve important unanswered clinical questions. Its rheumatologist sponsor urges you to encourage patients to join up.

Studies on banked cells from humans in different regions of the world reveal that many genes that control immune function behave differently in winter and summer. They are more pro-inflammatory in the winter.

Top reports chosen by Annals of Internal Medicine include several on biologics for rheumatoid arthritis and psoriatic arthritis, and mechanisms for lupus and scleroderma.

People have been busy creating decision aids to help involve patients in treatment choices. But rheumatologists prove lukewarm to the whole idea so far.

Pages

Subscribe to Rheumatic Diseases on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.